Adjuvant (AFT-19)

Study Information

Status: Active, Recruiting

Study Details

View study details on clinicaltrials.gov.

Locations

Palo Alto/Santa Cruz

Clinical Trial FAQs

Information for patients and study volunteers, including frequently asked questions.

Contact Us to Enroll

Description

A Phase 3 Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

Principal Investigator

Bryant C. Sheh, M.D.

Co-Investigator(s)

Natalia Colocci, M.D., Ph.D., Albert Pisani, M.D., Janet Wang, M.D., Huan T. Ha, M.D., Glenn D. Wong, D.O., Paula D. Kushlan, M.D., David S. Leibowitz, M.D., FACP, Edmund W. Tai, M.D., Priya Chakravarthi, M.D., Irene Wu, M.D., Michael C. Wu, M.D., Derrick Wong, M.D., Monique de Bruin, M.D., MPH, M. Dwight Chen, M.D., Kim-Son Nguyen, M.D., Gillian L. Hsieh, M.D.

Related Studies

Genomic Health Oncotype DX AR-V7

Genomic Health 09-060

Investigators: Kristie A. Bobolis, M.D., Vijay Suhag, M.D., Sivakumar Reddy, M.D., Rajeswari Chellappah, M.D., Brian K. Kim, M.D, David S Yee, M.D., MPH, Nitin Rohatgi, MD, Kristin N. Arreola, M.D.